Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-05-12
2010-06-29
Swope, Sheridan (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000
Reexamination Certificate
active
07745388
ABSTRACT:
Peptides able to inhibit or activate the translocation or function of δPKC are identified. Administration of the peptides for protection or enhancement of cell damage due to ischemia is described. Therapeutic methods to reduce damage to cells or to enhance damage to cells due to ischemia are also described, as well as methods for screening test compounds for δPKC-selective agonists and antagonists.
REFERENCES:
patent: 4708871 (1987-11-01), Geysen
patent: 5776716 (1998-07-01), Ron et al.
patent: 5783405 (1998-07-01), Mochly-Rosen et al.
patent: 6165977 (2000-12-01), Mochly-Rosen
patent: 6664040 (2003-12-01), Sherman et al.
patent: 6855693 (2005-02-01), Mochly-Rosen et al.
patent: 7265092 (2007-09-01), Li
patent: 7563772 (2009-07-01), Mochly-Rosen et al.
patent: 2004/0204364 (2004-10-01), Mochly-Rosen et al.
patent: 2008/0075706 (2008-03-01), Li
patent: 2009/0062208 (2009-03-01), Mochly-Rosen et al.
patent: 2009/0075901 (2009-03-01), Mochly-Rosen et al.
patent: 2009/0186814 (2009-07-01), Ikeno et al.
patent: 2009/0192089 (2009-07-01), Mochly-Rosen et al.
patent: WO 97/14038 (1997-04-01), None
patent: WO-2009/029678 (2009-03-01), None
Yoshida et al. (1999; Biochimica et Biophysica Acta 14: 230-238).
Miettinen et al. (1996; J. Neurosci 16(19): 6236-6245).
Miyawaki et al. (1997; Circulation Res. 80(6): 790).
Inagaki et al. (2000; Circulation 101)7): 797).
Chen et l. Circulation 102 (18 Supplement): pll. 120 Oct. 31, 2000.
Wells, Additivity of Mutational Effects in Proteins, Biochemistry, vol. 29, pp. 8509-8517(Sep. 18, 1990).
Chen, L., et al.,PNAS98(20):11114-11119, (2001).
Csukai, M. and Mochly-Rosen, D.,Pharmacological Research39(4):253-259, (1999).
Inagaki, K., et al.,Circulation101(7):797-804, (2000).
Johnson, J.A., et al.,Journal of Biological Chemistry271(40):24962-24966, (1996).
Shizukuda, Y. et al.,Circulation100(18):1909-1916, (1999).
Way, K.J., et al.,TiPS21(5):181-187, (2000).
Chen, C.H., et al.,PNAS, 96 (22): 12784-12789 (1999).
Mochly-Rosen,Science, 268: 247-251 (1995).
Mochly-Rosen, et al.,Proc. Natl. Acad. Sci. USA, 88: 3997-4000 (1991).
Wells, Biochemistry (1990) 29(37):8509-8517.
Inagaki et al., Circulation (2003) 108(7):869-875.
Inagaki et al., Circulation (2003) 108(19):2304-2307.
Nishikawa et al., Journal of Biological Chemistry (1997) 272(2):952-960.
Souroujon et al., Nature Biotechnology (1998) 16(10):919.
Supplementary European Search Report for EP 01 99 5483, mailed on Dec. 21, 2004, 7 pages.
Daria Mochly-Rosen, List of peptides provided for experimental use sent to Lobo Lab, University of California, San Francisco, San Francisco, California, US Feb. 11, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Sailen Barik, Department of Biochemistry and Molecular Biology, University of Southern Alabama, Mobile, Alabama, US Mar. 19, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Derek Miles Yellon, Hatter Institute for Cardiovascular Studies, Department of Academic and Clincial Cardiology, University of College Hospital and Medical School, London, UK Jun. 25, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Derek Miles Yellon, Hatter Institute for Cardiovascular Studies, Department of Academic and Clincial Cardiology, University of College Hospital and Medical School, London, UK Oct. 14, 1998.
Email to Dr. Dr. Derek Miles Yellon, Hatter Institute for Cardiovascular Studies, Department of Academic and Clincial Cardiology, University of College Hospital and Medical School, London, UK Oct. 14, 1998.
Email to Dr. Dr. Derek Miles Yellon, Hatter Institute for Cardiovascular Studies, Department of Academic and Clincial Cardiology, University of College Hospital and Medical School, London, UK Aug. 9, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Fiorenzo Battaini, Institute of Pharmacological Sciences, University of Milano Milano, IT, Oct. 15, 1998.
Email from Fiorenzo Battaini, Aug. 14, 1998.
Fiorenzo Battaini, Letter outlining project, Aug. 14, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Ashwani Malhotra, Cardiovascular Research Institute, New York Medical College, Valhalla, New York, US, Oct. 16, 1998.
Ashwanu Malhotra, List of peptides provided for expermiental use sent to Dr. Ashwani Malhotra, Cardiovascular Research Institute, New York Medical College, Valhalla, New York, US, Oct. 16, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Naoaki Saito, Laboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe, JP, Oct. 15, 1998.
Naoaki Saito, Email requesting peptidesList of peptides provided for expermiental use sent to Dr. Naoaki Saito, Laboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe, JP, Oct. 15, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Mohamed Boutjdir, Department of Cardiology, VA Medical Center, Brooklyn, New York, US, Aug. 14, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Drs. Rik Derynck and Huizhou Fan, Department of Growth and Development, University of California, San Francisco, San Francisco, California, US, Oct. 27, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Drs. Rik Derynck and Huizhou Fan, Department of Growth and Development, University of California, San Francisco, San Francisco, California, US, Oct. 26, 1998.
Purchase Order for PKC peptides, Department of Growth and Development, University of California, San Francisco, San Francisco, California, US, Oct. 26, 1998.
Daria Mochly-Rosen, Material Transfer Agreement and List of peptides provided for expermiental use sent to Drs. Rik Derynck and Huizhou Fan, Department of Growth and Development, University of California, San Francisco, San Francisco, California, US, Oct. 26, 1998.
Daria Mochly-Rosen, Email regarding request for peptides for expermiental use from Drs. Rik Derynck and Huizhou Fan, Department of Growth and Development, University of California, San Francisco, San Francisco, California, US, Sep. 11, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Marsha Rosner, Department of Pharmacological and Physiological Sciences, University of Chicago, Chicago, Illinois, US, Nov. 17, 1998.
Daria Mochly-Rosen, Email regarding request for peptides for expermiental use from Dr. Marsha Rosner, Oct. 27, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. John Hayslett, Yale School of Medicine, New Haven, Conneticut, US, Dec. 14, 1998.
John Hayslett, Letter to Dr. Mochly-Rosen requesting peptides, Oct. 28, 1998.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Guang S. Liu, Department of Physiology, University of South Alabama, Mobile, Alabama, US, Nov. 23, 1998.
Daria Mochly-Rosen, signed Material Transfer Agreement with Dr. Steven Pelech, Department of Medicine, University of British Columbia, Vancouver, B.C., CA, Feb. 10, 1999.
Daria Mochly-Rosen, Email to Dr. Steven Pelech regarding peptides, Feb. 8, 1999.
Daria Mochly-Rosen, Material Transfer Agreement to Dr. Pedro A. Jose, Georgetown University Hospital, Washington, D.C., US, Feb. 17, 1999.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Rafael Nesher, Department of Endocrinology, University of South Alabama, Mobile, Alabama, US, Feb. 10, 1999.
Daria Mochly-Rosen, Email to Dr. Rafael Nesher regarding peptides, Feb. 8, 1999.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Chaya Brodie, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel, Mar. 11, 1999.
Email traffic between Drs. Mochly-Rosen and Brodie regarding peptides.
Daria Mochly-Rosen, Material Transfer Agreement to Dr. Chaya Brodie, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel, Mar. 11, 1999.
Che-Hong Chen, List of peptides provided for expermiental use sent to Dr. Mireia Gomez-Angelats, National Institute of Environmental Health Sciences, RTP, NC, US, Jul. 13, 1999.
Chen Leon E.
Mochly-Rosen Daria
Morrison & Foerster / LLP
National Institute of Health (NIH)
Swope Sheridan
The United States of America as represented by NIH Division of E
The United States of America as represented by the Department of
LandOfFree
Peptides for activation and inhibition of δPKC does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for activation and inhibition of δPKC, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for activation and inhibition of δPKC will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4222017